🇺🇸 FDA
Patent

US 8759492

Engineered red-shifted channelrhodopsin variants

granted A61KA61K48/005

Quick answer

US patent 8759492 (Engineered red-shifted channelrhodopsin variants) held by The Regents of the University of California expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K48/005